Literature DB >> 24489088

CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.

Shuyu Yao1, Dan Huang, Crystal Y Chen, Lisa Halliday, Richard C Wang, Zheng W Chen.   

Abstract

The possibility that CD4(+) T cells can act as "innate-like" cells to contain very early Mycobacterium tuberculosis dissemination and function as master helpers to sustain multiple effector functions of CD8(+) T cells and CD3(-) lymphocytes during development of adaptive immunity against primary tuberculosis (TB) has not been demonstrated. We showed that pulmonary M. tuberculosis infection of CD4-depleted macaques surprisingly led to very early extrapulmonary M. tuberculosis dissemination, whereas CD4 deficiency clearly resulted in rapid TB progression. CD4 depletion during M. tuberculosis infection revealed the ability of CD8(+) T cells to compensate and rapidly differentiate to Th17-like/Th1-like and cytotoxic-like effectors, but these effector functions were subsequently unsustainable due to CD4 deficiency. Whereas CD3(-) non-T lymphocytes in the presence of CD4(+) T cells developed predominant Th22-like and NK-like (perforin production) responses to M. tuberculosis infection, CD4 depletion abrogated these Th22-/NK-like effector functions and favored IL-17 production by CD3(-) lymphocytes. CD4-depleted macaques exhibited no or few pulmonary T effector cells constitutively producing IFN-γ, TNF-α, IL-17, IL-22, and perforin at the endpoint of more severe TB, but they presented pulmonary IL-4(+) T effectors. TB granulomas in CD4-depleted macaques contained fewer IL-22(+) and perforin(+) cells despite the presence of IL-17(+) and IL-4(+) cells. These results implicate a previously unknown innate-like ability of CD4(+) T cells to contain extrapulmonary M. tuberculosis dissemination at very early stage. Data also suggest that CD4(+) T cells are required to sustain multiple effector functions of CD8(+) T cells and CD3(-) lymphocytes and to prevent rapid TB progression during M. tuberculosis infection of nonhuman primates.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24489088      PMCID: PMC4104690          DOI: 10.4049/jimmunol.1301373

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  74 in total

Review 1.  IL-17 and Th17 Cells.

Authors:  Thomas Korn; Estelle Bettelli; Mohamed Oukka; Vijay K Kuchroo
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

2.  Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses.

Authors:  Liyou Qiu; Dan Huang; Cystal Y Chen; Richard Wang; Ling Shen; Yun Shen; Robert Hunt; James Estep; Barton F Haynes; William R Jacobs; Norman Letvin; George Du; Zheng W Chen
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

3.  A vital role for interleukin-21 in the control of a chronic viral infection.

Authors:  John S Yi; Ming Du; Allan J Zajac
Journal:  Science       Date:  2009-05-14       Impact factor: 47.728

4.  Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.

Authors:  Joshua S Woodworth; Ying Wu; Samuel M Behar
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

5.  IL-21 is required to control chronic viral infection.

Authors:  Heidi Elsaesser; Karsten Sauer; David G Brooks
Journal:  Science       Date:  2009-05-07       Impact factor: 47.728

6.  IL-21R on T cells is critical for sustained functionality and control of chronic viral infection.

Authors:  Anja Fröhlich; Jan Kisielow; Iwana Schmitz; Stefan Freigang; Abdijapar T Shamshiev; Jacqueline Weber; Benjamin J Marsland; Annette Oxenius; Manfred Kopf
Journal:  Science       Date:  2009-05-28       Impact factor: 47.728

7.  Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates.

Authors:  Michelle H Larsen; Karolin Biermann; Bing Chen; Tsungda Hsu; Vasan K Sambandamurthy; Andrew A Lackner; Pyone Pyone Aye; Peter Didier; Dan Huang; Linyun Shao; Huiyong Wei; Norman L Letvin; Richard Frothingham; Barton F Haynes; Zheng W Chen; William R Jacobs
Journal:  Vaccine       Date:  2009-06-02       Impact factor: 3.641

Review 8.  Cell-mediated immune responses in tuberculosis.

Authors:  Andrea M Cooper
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 9.  Transcriptional regulation of Th17 cell differentiation.

Authors:  Ivaylo I Ivanov; Liang Zhou; Dan R Littman
Journal:  Semin Immunol       Date:  2007-11-28       Impact factor: 11.130

10.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more
  33 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

Review 2.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

3.  Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis.

Authors:  Jin-Cheng Zeng; Wen-Yu Xiang; Dong-Zi Lin; Jun-Ai Zhang; Gan-Bin Liu; Bin Kong; Yu-Chi Gao; Yuan-Bin Lu; Xian-Jing Wu; Lai-Long Yi; Ji-Xin Zhong; Jun-Fa Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 4.  The crucial roles of Th17-related cytokines/signal pathways in M. tuberculosis infection.

Authors:  Hongbo Shen; Zheng W Chen
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

Review 5.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

Review 6.  Th1 cytokines, true functional signatures for protective immunity against TB?

Authors:  Gucheng Zeng; Guoliang Zhang; Xinchun Chen
Journal:  Cell Mol Immunol       Date:  2017-11-20       Impact factor: 11.530

Review 7.  Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology.

Authors:  Joseph M Cicchese; Stephanie Evans; Caitlin Hult; Louis R Joslyn; Timothy Wessler; Jess A Millar; Simeone Marino; Nicholas A Cilfone; Joshua T Mattila; Jennifer J Linderman; Denise E Kirschner
Journal:  Immunol Rev       Date:  2018-09       Impact factor: 12.988

Review 8.  Immunology studies in non-human primate models of tuberculosis.

Authors:  JoAnne L Flynn; Hannah P Gideon; Joshua T Mattila; Philana Ling Lin
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

9.  Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4+ T Cells.

Authors:  Alison J Johnson; Steven C Kennedy; Cecilia S Lindestam Arlehamn; Michael F Goldberg; Neeraj K Saini; Jiayong Xu; Sinu Paul; Subray S Hegde; John S Blanchard; John Chan; William R Jacobs; Alessandro Sette; Steven A Porcelli
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

10.  Tuberculous pleurisy drives marked effector responses of γδ, CD4+, and CD8+ T cell subpopulations in humans.

Authors:  Jincheng Zeng; Zeqing Song; Xiaozhen Cai; Su Huang; Wandang Wang; Yanfen Zhu; Yinan Huang; Bin Kong; Wenyu Xiang; Dongzi Lin; Ganbin Liu; Junai Zhang; Crystal Y Chen; Hongbo Shen; Dan Huang; Ling Shen; Lailong Yi; Junfa Xu; Zheng W Chen
Journal:  J Leukoc Biol       Date:  2015-07-08       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.